Ascend Wellness Holdings (AAWH) Capital Expenditures (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Capital Expenditures came in at $5.2 million in Q1 2026, up 31.21% year-on-year from $3.9 million in Q1 2025, and up 130.53% quarter-over-quarter from -$17.0 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Capital Expenditures (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Capital Expenditures history runs 7 years deep, the most recent figure standing at $5.2 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 31.21% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 87.12% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 90.47% from the prior year.
  • Capital Expenditures grew to $5.2 million in Q1 2026 per AAWH's latest filing, from -$17.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $21.8 million in Q4 2024 and bottomed at -$17.0 million in Q4 2025.
  • The 5-year median for Capital Expenditures is $541000.0 (2024), against an average of $2.5 million.
  • Across the five-year window, Capital Expenditures surged 95400.0% in 2023 and tumbled 177.92% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at $7.0 million in 2022, then slumped by 105.19% to -$364000.0 in 2023, then jumped by 6082.14% to $21.8 million in 2024, then tumbled by 177.92% to -$17.0 million in 2025, then soared by 130.53% to $5.2 million in 2026.
  • Per Business Quant, the three latest AAWH Capital Expenditures figures stand at $5.2 million (Q1 2026), -$17.0 million (Q4 2025), and $6.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 5.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.18 Mn
Mar 31, 2026 5.18 Mn
Dec 31, 2025 -16.97 Mn
Dec 31, 2025 -16.97 Mn
Sep 30, 2025 6.45 Mn
Sep 30, 2025 6.45 Mn
Jun 30, 2025 8.72 Mn
Jun 30, 2025 8.72 Mn
Mar 31, 2025 3.95 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 21.78 Mn
Dec 31, 2024 21.78 Mn
Sep 30, 2024 541,000.00
Sep 30, 2024 541,000.00
Jun 30, 2024 -23,000.00
Jun 30, 2024 -23,000.00
Mar 31, 2024 241,000.00
Mar 31, 2024 241,000.00
Dec 31, 2023 -364,000.00
Dec 31, 2023 -364,000.00